Image may be NSFW.
Clik here to view.
Shares in AcelRx Pharmaceuticals (NSDQ:ACRX) rose today after the pharmaceutical company met expectations on Wall Street with its 4th quarter results.
The Redwood City, Calif.-based company pared its losses to -$9.7 million, or -21¢ per share, on sales of $6.4 million for the 3 months ended Dec. 31, for bottom-line growth of 8.2% on sales growth of 276.5% compared with the same period last year.
Adjusted to exclude 1-time items, losses per share were -21¢, ahead of the -24¢ consensus on The Street.
Get the full story at our sister site, Drug Delivery Business News.
The post AcelRx Pharmaceuticals gains on Q4 earnings appeared first on MassDevice.
